TrialPLoS medicine2022

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.

Zacchaeus Anywaine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.